Both in Pharmaceuticals
Mineralys Therapeutics vs Omeros
Over the past year MLYS returned −60.3% and OMER returned +148.7%; their daily moves had a correlation of 0.18.
MLYS −60.3% OMER +148.7%Growth of $1, one year, split-adjusted
| Metric | MLYS | OMER |
|---|---|---|
| Price | $15.55 | $17.83 |
| Market cap | $1.37B | $1.29B |
| Today | −14.47% | −3.31% |
| 1 month | −34.2% | −4.2% |
| 6 months | −47.6% | +19.6% |
| Year to date | −57.2% | +3.8% |
| 1 year | −62.2% | +137.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 97.2% |
| Net margin | — | 46.4% |
| P/E (TTM) | — | 10.3× |
| Price / sales | — | 33.6× |
| Net cash | $563.8M | $58.7M |
| Dividend yield | — | — |
| Volatility (60d) | 72.0% | 76.7% |
| Short % of float | 11.6% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).